Inhibition of human and rat 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase 3 activities by perfluoroalkylated substances

Chemico-Biological Interactions

Volumn 188, Issue 1, 2010, Pages 38-43

  Zhao, Binghai ^a,b   Hu, Guo Xin ^c   Chu, Yanhui ^b   Jin, Xiudong ^b   Gong, Shouliang ^d   Akingbemi, Benson T ^e   Zhang, Zhiqiang ^c   Zirkin, Barry R ^f   Ge, Ren Shan ^a,c  

^a POPULATION COUNCIL   (United States)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d JILIN UNIVERSITY   (China)

^e AUBURN UNIVERSITY   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

17 Hydroxysteroid dehydrogenase 3; 3 Hydroxysteroid dehydrogenase; Enzyme inhibition; Human; Perfluoroalkylated substances; PFOS; Rat

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ORGANOFLUORINE DERIVATIVE; PERFLUORO COMPOUND; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; POTASSIUM PERFLUOROBUTANESULFONIC ACID; POTASSIUM PERFLUOROHEXANESULFONIC ACID; POTASSIUM PERFLUOROOCTANESULFONIC ACID; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; 3 (OR 17)-BETA-HYDROXYSTEROID DEHYDROGENASE; ENZYME INHIBITOR; FLUOROCARBON; HYDROXYSTEROID DEHYDROGENASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; MICROSOME; NONHUMAN; TESTIS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; MALE; RAT;

17-HYDROXYSTEROID DEHYDROGENASES; 3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; ENZYME INHIBITORS; FLUOROCARBONS; HUMANS; MALE; RATS; TESTIS;

RATTUS;

EID: 77956174680     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.07.001     Document Type: Article

References (20)

1. Abdellatif A.G., Preat V., Vamecq J., Nilsson R., Roberfroid M. Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin. Carcinogenesis 1990, 11(11):1899-1902.
2. Jensen A.A., Leffers H. Emerging endocrine disrupters: perfluoroalkylated substances. Int. J. Androl. 2008, 31(2):161-169.
3. Johnson J.D., Gibson S.J., Ober R.E. Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. Fundam. Appl. Toxicol. 1984, 4(6):972-976.
4. Giesy J.P., Kannan K. Perfluorochemical surfactants in the environment. Environ. Sci. Technol. 2002, 36(7):146A-152A.
5. Olsen G.W., Mair D.C., Church T.R., Ellefson M.E., Reagen W.K., Boyd T.M., Herron R.M., Medhdizadehkashi Z., Nobiletti J.B., Rios J.A., Butenhoff J.L., Zobel L.R. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ. Sci. Technol. 2008, 42(13):4989-4995.
6. USEPA, O.R.A.Division Draft Risk Assessment of the Potential Human Health Effects Associated with Exposure to Perfluorooctanoic Acid and its Salts. AR2261136 2005, Washington, DC.
7. Chengelis C.P., Kirkpatrick J.B., Myers N.R., Shinohara M., Stetson P.L., Sved D.W. Comparison of the toxicokinetic behavior of perfluorohexanoic acid (PFHxA) and nonafluorobutane-1-sulfonic acid (PFBS) in cynomolgus monkeys and rats. Reprod. Toxicol. 2009, 27(3-4):400-406.
8. Olsen G.W., Gilliland F.D., Burlew M.M., Burris J.M., Mandel J.S., Mandel J.H. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J. Occup. Environ. Med. 1998, 40(7):614-622.
9. Gilliland F.D., Mandel J.S. Mortality among employees of a perfluorooctanoic acid production plant. J. Occup. Med. 1993, 35(9):950-954.
10. Biegel L.B., Liu R.C., Hurtt M.E., Cook J.C. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol. Appl. Pharmacol. 1995, 134(1):18-25.
11. Shi Z., Zhang H., Liu Y., Xu M., Dai J. Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicol. Sci. 2007, 98(1):206-215.
12. Chu Y., Zhao B., Huang Y., Hardy D.O., Li X.K., Ge R.S. Inhibition of 3β- and 17β-hydroxysteroid dehydrogenase activities in rat Leydig cells by PFOA. Asian J. Androl. 2009, 142:11.
13. Hu G.X., Zhou H.Y., Li X.W., Chen B.B., Xiao Y.C., Lian Q.Q., Liang G., Kim H.H., Zheng Z.Q., Hardy D.O., Ge R.S. The (+)- and (-)-gossypols potently inhibit both 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 in human and rat testes. J. Steroid Biochem. Mol. Biol. 2009, 115(1-2):14-19.
14. Hekster F.M., de Voogt A.M.P., Pijinenburg C.M., Laane R.W.P.M. Perfluoroalkylated Substances: Aquatic Environmental Assessment, Report RIKZ/2002.043. Prepared at the University of Amsterdam and RIKZ 2002, The State Institute for Coast and Sea, p. 99.
15. Bjork J.A., Wallace K.B. Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures. Toxicol. Sci. 2009, 111(1):89-99.
16. Ward K. DuPont Finds High C8 in Chinese Workers 2008, The Charleston Gazette.
17. Akingbemi B.T., Youker R.T., Sottas C.M., Ge R., Katz E., Klinefelter G.R., Zirkin B.R., Hardy M.P. Modulation of rat Leydig cell steroidogenic function by di(2-ethylhexyl)phthalate. Biol. Reprod. 2001, 65(4):1252-1259.
18. Huhtaniemi I., Pelliniemi L.J. Fetal Leydig cells: cellular origin, morphology, life span, and special functional features. Proc. Soc. Exp. Biol. Med. 1992, 201(2):125-140.
19. Ge R.S, Chen G.R., Dong Q., Akingbemi B., Sottas C.M., Santos M., Sealfon S.C., Bernard D.J., Hardy M.P. Biphasic effects of postnatal exposure to diethylhexylphthalate on the timing of puberty in male rats. J. Androl. 2007, 28(4):513-520.
20. Joensen U.N., Bossi R., Leffers H., Jensen A.A., Skakkebaek N.E., Jorgensen N. Do perfluoroalkyl compounds impair human semen quality?. Environ. Health Perspect. 2009, 117(6):923-927.